Elnora Completes a Clean SOC 2 Type 2 Attestation

Elnora AI completed a SOC 2 Type 2 attestation on 28 May 2026, receiving a clean, unqualified opinion on the Security trust services criteria. The examination covered a three-month operating period.

A Type 2 report differs from a Type 1 in what it tests. A Type 1 confirms that controls existed on a single date. A Type 2 examines whether they operated correctly across a period, with an auditor sampling evidence throughout. A clean unqualified opinion means no exceptions were reported.

The Security criteria cover how access to systems is granted and revoked, how changes are managed, how incidents are detected and handled, and how the platform is monitored. These are the questions that make up the bulk of a pharmaceutical vendor security assessment.

The attestation sits alongside the ISO/IEC 27001:2022 certificate Elnora received on 27 February 2026. The two overlap without duplicating: ISO 27001 certifies the management system, SOC 2 reports on how individual controls performed over time. Enterprise customers commonly ask for both.

The report is marked for restricted distribution, which is standard for SOC 2, and is released under a confidentiality agreement. Requests go through the Elnora Trust Center or press@elnora.ai.